Natera (NTRA) Current Deferred Revenue (2014 - 2026)
Natera (NTRA) reported Current Deferred Revenue of $36.9 million for Q1 2026, down 1.1% on a YoY basis from $37.3 million in Q1 2025, and up 47.96% quarter-over-quarter from $24.9 million in Q4 2025.
Natera (NTRA) Current Deferred Revenue (2014 - 2026) Analysis & Trends
Natera has reported Current Deferred Revenue for 13 years, with the latest figure at $36.9 million in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Revenue fell 1.1% year-over-year to $36.9 million; the trailing twelve-month figure through Mar 2026 stood at $36.9 million (down 1.1% YoY), and the FY2025 full-year result was $24.9 million, down 31.93% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $36.9 million, up from $24.9 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $37.3 million in Q1 2025, with the low at $7.9 million in Q3 2022.
- Historically, Current Deferred Revenue has averaged $21.4 million across 5 years, with a median of $17.9 million in 2024.
- Annual changes were most pronounced in 2023 — Current Deferred Revenue surged 231.63% — and 2025, when it sank 31.93%.
- Natera's Current Deferred Revenue stood at $10.8 million in 2022, then surged by 231.63% to $35.7 million in 2023, then gained by 2.38% to $36.6 million in 2024, then sank by 31.93% to $24.9 million in 2025, then surged by 47.96% to $36.9 million in 2026.
- The last three Current Deferred Revenue figures came in at $36.9 million (Q1 2026), $24.9 million (Q4 2025), and $21.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.85 Mn |
| Dec 31, 2025 | 24.91 Mn |
| Sep 30, 2025 | 21.79 Mn |
| Jun 30, 2025 | 21.56 Mn |
| Mar 31, 2025 | 37.26 Mn |
| Dec 31, 2024 | 36.59 Mn |
| Sep 30, 2024 | 17.89 Mn |
| Jun 30, 2024 | 18.37 Mn |
| Mar 31, 2024 | 17.71 Mn |
| Dec 31, 2023 | 35.74 Mn |
| Sep 30, 2023 | 15.01 Mn |
| Jun 30, 2023 | 15.64 Mn |
| Mar 31, 2023 | 16.58 Mn |
| Dec 31, 2022 | 10.78 Mn |
| Sep 30, 2022 | 7.93 Mn |
| Jun 30, 2022 | 16.01 Mn |
| Mar 31, 2022 | 13.91 Mn |
| Dec 31, 2021 | 7.40 Mn |
| Sep 30, 2021 | 9.67 Mn |
| Jun 30, 2021 | 10.65 Mn |